Ariel Aday, M.D.

Ariel Aday, M.D., is an Assistant Professor in the Department of Internal Medicine at UT Southwestern Medical Center, and a member of the Division of Digestive and Liver Diseases. She is the Associate Director of the Gastroenterology Fellowship Program. Her clinical and research interests include cirrhosis, alcoholic liver disease, women’s health, and nutrition.

Originally from Bristol, Tennessee, Dr. Aday holds a bachelor’s degree in biology from the University of North Carolina at Chapel Hill, which included studying abroad in experimental psychology at Oxford University. She received her medical degree from Wake Forest University School of Medicine and completed internal medicine residency training at the Universidad Peruana Cayetano Heredia in Lima, Peru, and at UT Southwestern, where she was Chief Medical Resident in her final year. She then completed advanced training through a fellowship in gastroenterology at UT Southwestern.

Certified by the American Board of Internal Medicine in gastroenterology, Dr. Aday joined the UT Southwestern Faculty in 2015.

Dr. Aday’s research interests include cirrhosis, alcoholic liver disease, women’s health, and nutrition. Her investigations have resulted in more than a dozen publications in peer-reviewed journals and contributions to book chapters and editorials.

She is active in several professional societies, including the Texas Society for Gastroenterology and Endoscopy, the American Neurogastroenterology and Motility Society, the Texas Medical Association, and the Alliance for Academic Internal Medicine.

Personal Note

Dr. Aday’s interests outside of medicine include spending time with her family, traveling, and fitness.

Medical School

Wake Forest University School of Medicine (2012)

Internship

UT Southwestern Medical Center (2013), Internal Medicine

Residency

UT Southwestern Medical Center (2015), Internal Medicine

Fellowship

UT Southwestern Medical Center (2019), Gastroenterology

• Acute on Chronic Liver Failure
• Liver Disease in Pregnancy
• Nutrition

Featured Publications

Alcoholic hepatitis: current trends in management.

Aday AW, Mitchell MC, Casey LC Curr. Opin. Gastroenterol. 2017 Mar

The Beneficial Effect of Beta-Blockers in Patients With Cirrhosis, Portal Hypertension and Ascites.

Aday AW, Mayo MJ, Elliott A, Rockey DC Am. J. Med. Sci. 2016 Feb 351 2 169-76

DSA's Meaningful Impact on Liver Transplantation.

Aday AW, O'Leary JG Liver Transpl. 2018 Jul

An unusual rash in a middle-aged man.

Pandey A, Aday A J Gen Intern Med 2014 Dec 29 12 1711-2

An essential role for the association of CD47 to SHPS-1 in skeletal remodeling.

Maile LA, DeMambro VE, Wai C, Lotinun S, Aday AW, Capps BE, Beamer WG, Rosen CJ, Clemmons DR J. Bone Miner. Res. 2011 Sep 26 9 2068-81

Integrin-associated protein association with SRC homology 2 domain containing tyrosine phosphatase substrate 1 regulates igf-I signaling in vivo.

Maile LA, Capps BE, Miller EC, Aday AW, Clemmons DR Diabetes 2008 Oct 57 10 2637-43

Modulation of integrin antagonist signaling by ligand binding of the heparin-binding domain of vitronectin to the alphaVbeta3 integrin.

Maile LA, Aday AW, Busby WH, Sanghani R, Veluvolu U, Clemmons DR J. Cell. Biochem. 2008 Oct 105 2 437-46

Glucose regulation of integrin-associated protein cleavage controls the response of vascular smooth muscle cells to insulin-like growth factor-I.

Maile LA, Capps BE, Miller EC, Allen LB, Veluvolu U, Aday AW, Clemmons DR Mol. Endocrinol. 2008 May 22 5 1226-37

• AASLD Liver Cup
  National Debate Winner (2017)
• Global Health Initiative
  First UT Southwestern representative at Universidad Peruana Cayetano Heredia in Lima, Peru (2015)
• Residency Council
  Representative, peer-selected committee (2012-2015)
• Ann Eller Pardue Endowed Scholarship
  (2008-2010)

• American Association for the Study of Liver Diseases (2016)
• American College of Physicians (2012)
• American Gastroenterology Association (2016)